Bruker AXS to Acquire X-Ray Analysis Software Company SOCABIMNext generation DIFFRACPlus Eva XRD software provides a unique, ful
August 16 2005 - 7:00AM
Business Wire
Bruker AXS GmbH today announces that it has signed a binding
agreement to acquire all shares of privately-held SOCABIM SAS, a
company focused on advanced X-ray materials research and analysis
software. The transaction is expected to close in the first quarter
of 2006. SOCABIM was founded in 1977 and has developed into a major
supplier of software for X-ray diffraction (XRD) and X-ray
fluorescence (XRF) materials analysis to Bruker AXS. With this
acquisition, Bruker AXS is significantly expanding its core
technology base in two of its strategic product and applications
areas. The acquisition will not add to Bruker AXS' revenue, but is
expected to increase the Bruker AXS gross margin by more than one
percent. For Bruker BioSciences Corporation the transaction is
expected to be accretive by $0.01 per share in 2006. Bruker AXS
intends to merge and co-locate SOCABIM SAS and its French
subsidiary Bruker AXS SA near Paris. The two co-founders of
SOCABIM, Mr. Julien Nusinovici and Mr. Pierre Caussin, as well as
all present employees of SOCABIM, are expected to join the merged
company, with Mr. Nusinovici and Mr. Caussin continuing their role
as senior managers of the SOCABIM division of the merged company.
Dr. Frank Burgazy, Managing Director of Bruker AXS GmbH and
President of Bruker AXS SA in France, said: "We are very excited
about this acquisition and we welcome our new SOCABIM colleagues to
Bruker AXS. The already high quality and good market acceptance of
the SOCABIM software should be further increased by our strategic
integration of the SOCABIM software R&D. We believe that with
the addition of the SOCABIM technology and R&D team, our
products can accelerate their 'time-to-market', and our X-ray
systems for advanced research and process analysis in the
nanomaterials, thin film, composite materials, semiconductor and
basic materials industries will be even more powerful and
user-friendly." Mr. Julien Nusinovici, President of SOCABIM SAS,
added: "My SOCABIM colleagues and I are very pleased to join Bruker
AXS, where we see an excellent opportunity to continue our
successful software development work in an integrated X-ray
analysis solutions environment. We look forward to contributing
significantly to the success of Bruker AXS in the future." ABOUT
BRUKER BIOSCIENCES (NASDAQ: BRKR) Bruker BioSciences Corporation,
headquartered in Billerica, Massachusetts, is the publicly traded
parent company of Bruker Daltonics Inc. and Bruker AXS Inc. Bruker
AXS is a leading developer and provider of life science and
advanced materials research tools based on x-ray technology. Bruker
Daltonics is a leading developer and provider of innovative life
science tools based on mass spectrometry. For more information,
please visit www.bruker-biosciences.com. CAUTIONARY STATEMENT Any
statements contained in this press release that do not describe
historical facts may constitute forward-looking statements as that
term is defined in the Private Securities Litigation Reform Act of
1995. Any forward-looking statements contained herein are based on
current expectations, but are subject to a number of risks and
uncertainties. The factors that could cause actual future results
to differ materially from current expectations include, but are not
limited to, risks and uncertainties relating to the Company's
reorganization strategies, integration risks, failure of
conditions, technological approaches, product development, market
acceptance, cost and pricing of the Company's products, exposure to
currency fluctuations, changes in governmental regulations, capital
spending and government funding policies, FDA and other regulatory
approvals to the extent applicable, competition, the intellectual
property of others, patent protection and litigation. These and
other factors are identified and described in more detail in our
filings with the SEC, including, without limitation, our respective
annual reports on Form 10-K for the year ended December 31, 2004,
our most recent quarterly reports on Form 10-Q, and our current
reports on Form 8-K. We disclaim any intent or obligation to update
these forward-looking statements.
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Sep 2023 to Sep 2024